New technologies in the genetic approach to sudden cardiac death in the young

Forensic Science International

Volumn 203, Issue 1-3, 2010, Pages 15-24

  Brion, M ^a,b   Quintela, I ^a   Sobrino, B ^a   Torres, M ^a   Allegue, C ^a,b   Carracedo, A ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Arrythmogenic diseases; Cardiomyopathies; Genome wide association studies; Mutation screening; Next generation sequencing; Sudden cardiac death

Indexed keywords

GENOMIC DNA;

ARTICLE; CARDIOMYOPATHY; DNA DETERMINATION; DNA HYBRIDIZATION; DNA SEQUENCE; DNA TEMPLATE; FORENSIC GENETICS; FORENSIC PATHOLOGY; GENE MAPPING; GENE TARGETING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; HUMAN; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; MUTATIONAL ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; SINGLE NUCLEOTIDE POLYMORPHISM; SUDDEN DEATH;

EID: 78649321882     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.07.015     Document Type: Review

References (89)

1. Sen-Chowdhry S., McKenna W.J. Sudden cardiac death in the young: a strategy for prevention by targeted evaluation. Cardiology 2006, 105:196-206.
2. Basso C., Calabrese F., Corrado D., Thiene G. Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings. Cardiovasc. Res. 2001, 50:290-300.
3. Tan H.L, Hofman N., van Langen I.M., van der Wal A.C., Wilde A.A. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005, 112:207-213.
4. Priori S.G., Aliot E., Blomstrom-Lundqvist C., et al. Task force on sudden cardiac death of the European society of cardiology. Eur. Heart J. 2001, 22:1374-1450.
5. Rodriguez-Calvo M.S., Brion M., Allegue C., Concheiro L., Carracedo A. Molecular genetics of sudden cardiac death. Forensic Sci. Int. 2008, 182:1-12.
6. Tester D.J., Ackerman M.J. Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children. Annu. Rev. Med. 2009, 60:69-84.
7. Genetic diagnostics and genetic counselling in hypertrophic cardiomyopathy (HCM), Neth. Heart J., 18 (2010) 144-159.
8. Marcus F.I., McKenna W.J., Sherrill D., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010, 121:1533-1541.
9. Hedley P.L., Jorgensen P., Schlamowitz S., et al. The genetic basis of long QT and short QT syndromes: a mutation update. Hum. Mutat. 2009, 30:1486-1511.
10. Pfeufer A., Sanna S., Arking D.E., et al. Common variants at ten loci modulate the QT interval duration in the QTSCD Study. Nat. Genet. 2009, 41:407-414.
11. Newton-Cheh C., Eijgelsheim M., Rice K.M., et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat. Genet. 2009, 41:399-406.
12. Oeth P., del Mistro G., Marnellos G., Shi T., van den Boom D. Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY). Methods Mol. Biol. 2009, 578:307-343.
13. Allegue C., Gil R., Sanchez-Diz P., et al. A new approach to long QT syndrome mutation detection by Sequenom MassArray system. Electrophoresis 2010, 31:1648-1655.
14. Brion M., Allegue C., Monserrat L., et al. Large scale analysis of HCM mutations in sudden cardiac death. Forensic Sci. Int.: Genet. Suppl. Ser. 2008, 1:549-550.
15. Kurg A., Tonisson N., Georgiou I., et al. Arrayed primer extension: solid-phase four-color DNA resequencing and mutation detection technology. Genet. Test. 2000, 4:1-7.
16. Krjutskov K., Andreson R., Magi R., et al. Development of a single tube 640-plex genotyping method for detection of nucleic acid variations on microarrays. Nucleic Acids Res. 2008, 36:e75.
17. Lin C.H., Yeakley J.M., McDaniel T.K., Shen R. Medium- to high-throughput SNP genotyping using VeraCode microbeads. Methods Mol. Biol. 2009, 496:129-142.
18. Kutyavin I.V., Afonina I.A., Mills A., et al. 3′-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res. 2000, 28:655-661.
19. Holland P.M., Abramson R.D., Watson R., Gelfand D.H. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:7276-7280.
20. Lee L.G., Connell C.R., Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 1993, 21:3761-3766.
21. Hernesniemi J.A., Karhunen P.J., Oksala N., et al. Interleukin 18 gene promoter polymorphism: a link between hypertension and pre-hospital sudden cardiac death: the Helsinki Sudden Death Study. Eur. Heart J. 2009, 30:2939-2946.
22. Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
23. Turner E.H., Ng S.B., Nickerson D.A., Shendure J. Methods for genomic partitioning. Annu. Rev. Genomics Hum. Genet. 2009, 10:263-284.
24. Mamanova L., Coffey A.J., Scott C.E., et al. Target-enrichment strategies for next-generation sequencing. Nat. Methods 2010, 7:111-118.
25. Yeager M., Xiao N., Hayes R.B., et al. Comprehensive resequence analysis of a 136kb region of human chromosome 8q24 associated with prostate and colon cancers. Hum. Genet. 2008, 124:161-170.
26. Tewhey R., Warner J.B., Nakano M., et al. Microdroplet-based PCR enrichment for large-scale targeted sequencing. Nat. Biotechnol. 2009, 27:1025-1031.
27. Hardenbol P., Baner J., Jain M., et al. Multiplexed genotyping with sequence-tagged molecular inversion probes. Nat. Biotechnol. 2003, 21:673-678.
28. Hardenbol P., Yu F., Belmont J., et al. Highly multiplexed molecular inversion probe genotyping: over 10,000 targeted SNPs genotyped in a single tube assay. Genome Res. 2005, 15:269-275.
29. Porreca G.J., Zhang K., Li J.B., et al. Multiplex amplification of large sets of human exons. Nat. Methods 2007, 4:931-936.
30. Turner E.H., Lee C., Ng S.B., Nickerson D.A., Shendure J. Massively parallel exon capture and library-free resequencing across 16 genomes. Nat. Methods 2009, 6:315-316.
31. Albert T.J., Molla M.N., Muzny D.M., et al. Direct selection of human genomic loci by microarray hybridization. Nat. Methods 2007, 4:903-905.
32. Hodges E., Xuan Z., Balija V., et al. Genome-wide in situ exon capture for selective resequencing. Nat. Genet. 2007, 39:1522-1527.
33. Okou D.T., Steinberg K.M., Middle C., et al. Microarray-based genomic selection for high-throughput resequencing. Nat. Methods 2007, 4:907-909.
34. Ng S.B., Turner E.H., Robertson P.D., et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461:272-276.
35. Bau S., Schracke N., Kranzle M., et al. Targeted next-generation sequencing by specific capture of multiple genomic loci using low-volume microfluidic DNA arrays. Anal. Bioanal. Chem. 2009, 393:171-175.
36. Summerer D., Wu H., Haase B., et al. Microarray-based multicycle-enrichment of genomic subsets for targeted next-generation sequencing. Genome Res. 2009, 19:1616-1621.
37. Gnirke A., Melnikov A., Maguire J., et al. Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat. Biotechnol. 2009, 27:182-189.
38. Dressman D., Yan H., Traverso G., Kinzler K.W., Vogelstein B. Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8817-8822.
39. Adessi C., Matton G., Ayala G., et al. Solid phase DNA amplification: characterisation of primer attachment and amplification mechanisms. Nucleic Acids Res. 2000, 28:E87.
40. Fedurco M., Romieu A., Williams S., Lawrence I., Turcatti G. BTA, a novel reagent for DNA attachment on glass and efficient generation of solid-phase amplified DNA colonies. Nucleic Acids Res. 2006, 34:e22.
41. Margulies M., Egholm M., Altman W.E., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 2005, 437:376-380.
42. Ronaghi M., Karamohamed S., Pettersson B., Uhlen M., Nyren P. Real-time DNA sequencing using detection of pyrophosphate release. Anal. Biochem. 1996, 242:84-89.
43. Turcatti G., Romieu A., Fedurco M., Tairi A.P. A new class of cleavable fluorescent nucleotides: synthesis and optimization as reversible terminators for DNA sequencing by synthesis. Nucleic Acids Res. 2008, 36:e25.
44. Valouev A., Ichikawa J., Tonthat T., et al. A high-resolution, nucleosome position map of C. elegans reveals a lack of universal sequence-dictated positioning. Genome Res. 2008, 18:1051-1063.
45. Braslavsky I., Hebert B., Kartalov E., Quake S.R. Sequence information can be obtained from single DNA molecules. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:3960-3964.
46. Pushkarev D., Neff N.F., Quake S.R. Single-molecule sequencing of an individual human genome. Nat. Biotechnol. 2009, 27:847-852.
47. Ashley E.A., Butte A.J., Wheeler M.T., et al. Clinical assessment incorporating a personal genome. Lancet 2010, 375:1525-1535.
48. Wang D.G., Fan J.B., Siao C.J., et al. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 1998, 280:1077-1082.
49. Waldmuller S., Muller M., Rackebrandt K., et al. Array-based resequencing assay for mutations causing hypertrophic cardiomyopathy. Clin. Chem. 2008, 54:682-687.
50. Fokstuen S., Lyle R., Munoz A., et al. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy. Hum. Mutat. 2008, 29:879-885.
51. Carlson C.S., Eberle M.A., Kruglyak L., Nickerson D.A. Mapping complex disease loci in whole-genome association studies. Nature 2004, 429:446-452.
52. The International HapMap Project. Nature 2003, 426:789-796.
53. A haplotype map of the human genome. Nature 2005, 437:1299-1320.
54. Frazer K.A., Ballinger D.G., Cox D.R., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861.
55. Klein R.J., Zeiss C., Chew E.Y., et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005, 308:385-389.
56. Genome-wide association study of 14,000 cases of seven common diseases and 3000 shared controls. Nature 2007, 447:661-678.
57. Hindorff L.A., Sethupathy P., Junkins H.A., et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9362-9367.
58. Redon R., Ishikawa S., Fitch K.R., et al. Global variation in copy number in the human genome. Nature 2006, 444:444-454.
59. Freeman J.L., Perry G.H., Feuk L., et al. Copy number variation: new insights in genome diversity. Genome Res. 2006, 16:949-961.
60. McCarroll S.A., Altshuler D.M. Copy-number variation and association studies of human disease. Nat. Genet. 2007, 39:S37-42.
61. McCarroll S.A. Extending genome-wide association studies to copy-number variation. Hum. Mol. Genet. 2008, 17:R135-R142.
62. Craddock N., Hurles M.E., Cardin N., et al. Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3000 shared controls. Nature 2010, 464:713-720.
63. Nolte I.M., Wallace C., Newhouse S.J., et al. Common genetic variation near the phospholamban gene is associated with cardiac repolarisation: meta-analysis of three genome-wide association studies. PLoS One 2009, 4:e6138.
64. George A.L. Common genetic variants in sudden cardiac death. Heart Rhythm 2009, 6:S3-S9.
65. Arking D.E., Reinier K., Post W., et al. Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest. PLoS One 2010, 5:e9879.
66. Gu Y., Harley I.T., Henderson L.B., et al. Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009, 458:1039-1042.
67. Yoshida T., Kato K., Yokoi K., et al. Association of genetic variants with myocardial infarction in Japanese individuals with different lipid profiles. Int. J. Mol. Med. 2010, 25:607-616.
68. Steemers F.J., Gunderson K.L. Whole genome genotyping technologies on the BeadArray platform. Biotechnol. J. 2007, 2:41-49.
69. Maresso K., Broeckel U. Genotyping platforms for mass-throughput genotyping with SNPs, including human genome-wide scans. Adv. Genet. 2008, 60:107-139.
70. Earl J., Greenhalf W. Single-nucleotide polymorphism (SNP) analysis to associate cancer risk. Methods Mol. Biol. 2010, 576:171-196.
71. Talmud P.J., Drenos F., Shah S., et al. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am. J. Hum. Genet. 2009, 85:628-642.
72. Humphries S.E., Drenos F., Ken-Dror G., Talmud P.J. Coronary heart disease risk prediction in the era of genome-wide association studies: current status and what the future holds. Circulation 2010, 121:2235-2248.
73. Ng S.B., Buckingham K.J., Lee C., et al. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42:30-35.
74. Hoischen A., van Bon B.W., Gilissen C., et al. De novo mutations of SETBP1 cause Schinzel-Giedion syndrome. Nat. Genet. 2010, 42:483-485.
75. van Spaendonck-Zwarts K.Y., van den Berg M.P., van Tintelen J.P. DNA analysis in inherited cardiomyopathies: current status and clinical relevance. Pacing Clin. Electrophysiol. 2008, 31(Suppl. 1):S46-S49.
76. Basso C., Carturan E., Pilichou K., et al. Sudden cardiac death with normal heart molecular autopsy. Cardiovasc. Pathol. 2010, Epub ahead of print.
77. Oliva A., Brugada R., D'Aloja E., et al. State of the art in forensic investigation of sudden cardiac death. Am. J. Forensic Med. Pathol 2010, Epub ahead of print.
78. Kotoula V., Charalambous E., Biesmans B., et al. Targeted KRAS mutation assessment on patient tumor histologic material in real time diagnostics. PLoS One 2009, 4:e7746.
79. Lips E.H., Dierssen J.W., van Eijk R., et al. Reliable high-throughput genotyping and loss-of-heterozygosity detection in formalin-fixed, paraffin-embedded tumors using single nucleotide polymorphism arrays. Cancer Res. 2005, 65:10188-10191.
80. Tuefferd M., De Bondt A., Van Den Wyngaert I., et al. Genome-wide copy number alterations detection in fresh frozen and matched FFPE samples using SNP 6.0 arrays. Genes Chromosomes Cancer 2008, 47:957-964.
81. Oosting J., Lips E.H., van Eijk R., et al. High-resolution copy number analysis of paraffin-embedded archival tissue using SNP BeadArrays. Genome Res. 2007, 17:368-376.
82. Wood H.M., Belvedere O., Conway C., et al. Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens. Nucleic Acids Res. 2010, Epub ahead of print.
83. Schweiger M.R., Kerick M., Timmermann B., et al. Genome-wide massively parallel sequencing of formaldehyde fixed-paraffin embedded (FFPE) tumor tissues for copy-number- and mutation-analysis. PLoS One 2009, 4:e5548.
84. Andersen P.S., Havndrup O., Hougs L., et al. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives. Hum. Mutat. 2009, 30:363-370.
85. Maron B.J, McKenna W.J., Danielson G.K., et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J. Am. Coll. Cardiol. 2003, 42:1687-1713.
86. Bai R., Napolitano C., Bloise R., Monteforte N., Priori S.G. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Circ. Arrhythm Electrophysiol. 2009, 2:6-15.
87. Campuzano O., Beltran-Alvarez P., Iglesias A., et al. Genetics and cardiac channelopathies. Genet. Med. 2010, 12:260-267.
88. Stenson P.D., Mort M., Ball E.V., et al. The human gene mutation database: 2008 update. Genome Med. 2009, 1:13.
89. Barrett J.C., Cardon L.R. Evaluating coverage of genome-wide association studies. Nat. Genet. 2006, 38:659-662.